In fact, CDKN2A germline mutations have been identified in less than 2% of single primary melanoma cases, 8-12% of sporadic MPM cases and 47% of MPM patients with familial melanoma (fM) [4,5]. This evidence concerns the gene CDKN2A and melanoma.